世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Vitreoretinal Surgery Device Market in Japan

Vitreoretinal Surgery Device Market in Japan


Vitreoretinal Surgery Device in Japan Trends and Forecast The future of the vitreoretinal surgery device market in Japan looks promising, with opportunities in the anterior vitreoretinal surgery... もっと見る

 

 

出版社 出版年月 電子版価格 納期 言語
Lucintel
ルシンテル
2025年11月10日 US$3,850
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
オンデマンドレポート:ご注文後3-4週間 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

本レポートは受注生産のため、2~3営業日程度ご納品のお時間をいただく場合がございます。


 

Summary

Vitreoretinal Surgery Device in Japan Trends and Forecast

The future of the vitreoretinal surgery device market in Japan looks promising, with opportunities in the anterior vitreoretinal surgery and posterior vitreoretinal surgery markets. The global vitreoretinal surgery device market is expected to grow with a CAGR of 3.5% from 2025 to 2031. The vitreoretinal surgery device market in Japan is also forecasted to witness strong growth over the forecast period. The major drivers for this market are the rising rate of ocular disorders, the growing number of vitreoretinal surgeries, and the increasing preference towards minimally invasive vitreoretinal surgical procedures.

• Lucintel forecasts that, within the product type category, perfluorocarbon liquid is expected to witness the highest growth over the forecast period.
• Within the surgery type category, posterior vitreoretinal surgery is expected to witness a higher growth over the forecast period.


Emerging Trends in the Vitreoretinal Surgery Device Market in Japan

The vitreoretinal surgery device market in Japan is experiencing rapid evolution driven by technological advancements, increasing prevalence of retinal diseases, and a growing aging population. These factors are fostering innovation and expanding market opportunities. Companies are investing heavily in research and development to introduce more precise, minimally invasive, and user-friendly devices. Regulatory support and collaborations between tech firms and healthcare providers are further accelerating growth. As a result, the market is witnessing a shift towards smarter, integrated, and more efficient surgical solutions that aim to improve patient outcomes and reduce procedure times.

• Technological Innovation: The market is witnessing significant technological advancements, including the development of high-definition imaging systems, 3D visualization, and robotic-assisted surgeries. These innovations enhance surgical precision, reduce complications, and improve patient outcomes. Companies are focusing on integrating artificial intelligence and machine learning to assist surgeons during procedures. The adoption of these advanced technologies is expected to increase, making surgeries safer and more efficient. This trend is transforming traditional surgical methods into more sophisticated, data-driven processes.
• Growing Prevalence of Retinal Diseases: An aging population in Japan is leading to a rise in retinal diseases such as age-related macular degeneration and diabetic retinopathy. This increasing prevalence is driving demand for advanced vitreoretinal surgical devices. Healthcare providers are seeking more effective tools to manage complex cases, which in turn fuels innovation in device design and functionality. The market is expanding as new devices are developed to address the specific needs of these patient groups, ultimately improving treatment outcomes.
• Minimally Invasive Procedures: There is a strong shift towards minimally invasive surgical techniques in vitreoretinal procedures. Smaller incisions, reduced trauma, and faster recovery times are key benefits driving this trend. Devices that facilitate these procedures are gaining popularity among surgeons and patients alike. This shift is also influenced by technological improvements that enable more precise and less invasive interventions. The demand for such devices is expected to grow, reshaping surgical practices and patient care standards.
• Regulatory and Reimbursement Changes: Evolving regulatory frameworks and reimbursement policies in Japan are impacting the market landscape. Streamlined approval processes for innovative devices encourage manufacturers to introduce new products. Additionally, favorable reimbursement policies incentivize healthcare providers to adopt advanced vitreoretinal devices. These changes are fostering a more dynamic market environment, encouraging innovation and competition. As a result, the availability of cutting-edge devices is increasing, benefiting both clinicians and patients.
• Strategic Collaborations and Market Expansion: Companies are forming strategic alliances with research institutions, healthcare providers, and technology firms to accelerate product development and market penetration. These collaborations facilitate access to new technologies and expertise, enabling the creation of more advanced devices. Market expansion efforts are also targeting rural and underserved areas to improve access to vitreoretinal surgeries. Such strategic initiatives are vital for sustaining growth and maintaining competitive advantage in Japanese evolving market.

These emerging trends are collectively reshaping the vitreoretinal surgery device market in Japan by fostering innovation, improving surgical outcomes, and expanding access. Technological advancements and minimally invasive techniques are setting new standards for patient care. Regulatory support and strategic collaborations are accelerating product development and market penetration. As a result, the market is becoming more competitive, dynamic, and patient-centric, ultimately leading to better management of retinal diseases and enhanced quality of life for patients.

Recent Developments in the Vitreoretinal Surgery Device Market in Japan

The vitreoretinal surgery device market in Japan is experiencing rapid advancements driven by technological innovations, increasing prevalence of retinal diseases, and a growing aging population. These developments are enhancing surgical precision, safety, and patient outcomes, thereby transforming clinical practices. The integration of digital imaging, miniaturization of devices, and adoption of AI are notable trends shaping the market landscape. Additionally, collaborations between device manufacturers and healthcare providers are fostering innovation and expanding market reach. These key developments are collectively propelling the growth of the vitreoretinal surgery device market in Japan, making it more efficient and accessible.

• Advanced Digital Imaging Systems: The adoption of high-resolution digital imaging enhances visualization during surgeries, improving precision and outcomes. These systems allow real-time image processing, aiding surgeons in complex procedures and reducing operative time. The integration of 3D visualization technology is further revolutionizing surgical accuracy. This development is attracting more ophthalmic surgeons to adopt advanced devices, thereby expanding the market. It also facilitates better training and education, ultimately improving patient care standards.
• Miniaturization of Surgical Instruments: The trend towards smaller, more ergonomic devices is making surgeries less invasive and more comfortable for patients. Miniaturized instruments reduce trauma to ocular tissues, leading to faster recovery times and fewer complications. This innovation is enabling surgeons to perform more delicate procedures with higher precision. The market benefits from increased demand for such advanced tools, especially in complex retinal surgeries. Manufacturers are investing heavily in R&D to develop compact, efficient devices, which is fueling market growth.
• Integration of Artificial Intelligence (AI): AI-powered systems are being incorporated to assist in diagnostics, surgical planning, and intraoperative decision-making. These systems improve accuracy, reduce human error, and optimize surgical outcomes. AI-driven analytics help in the early detection of retinal diseases, enabling timely intervention. The adoption of AI is also streamlining workflow and reducing procedure times. This technological leap is attracting investments and fostering innovation, positioning Japan as a leader in AI-enabled vitreoretinal surgery devices.
• Telemedicine and Remote Surgery Capabilities: The COVID-19 pandemic accelerated the adoption of telemedicine, including remote surgical assistance. Advanced devices now support real-time remote monitoring and guidance, expanding access to specialized care in remote areas. This development is crucial for Japanese aging population, providing timely interventions without the need for travel. It also opens new avenues for training and collaboration across regions. The market is witnessing increased interest and investment in remote surgical technologies, promising broader reach and improved patient outcomes.
• Strategic Collaborations and Market Expansion: Partnerships between device manufacturers, research institutions, and healthcare providers are driving innovation and market penetration. These collaborations facilitate the development of cutting-edge technologies tailored to Japanese clinical needs. They also enable faster regulatory approvals and commercialization. Market expansion efforts include entry into new regional markets and diversification of product portfolios. Such strategic alliances are vital for sustaining growth and maintaining competitive advantage in Japanese dynamic vitreoretinal device market.

These technological and strategic developments are significantly impacting the vitreoretinal surgery device market in Japan by enhancing surgical precision, safety, and accessibility. They are fostering innovation, expanding market reach, and improving patient outcomes, thereby driving sustained growth in the sector.

Strategic Growth Opportunities for Vitreoretinal Surgery Device Market in Japan

The vitreoretinal surgery device market in Japan is experiencing rapid growth driven by technological advancements and the increasing prevalence of retinal diseases. As the healthcare landscape evolves, key applications are presenting significant opportunities for market expansion. Innovations in surgical tools, imaging systems, and minimally invasive techniques are transforming treatment approaches. These developments are not only improving patient outcomes but also expanding the scope of procedures performed. Strategic investments and collaborations are further fueling growth, making Japan a pivotal market for vitreoretinal devices. Understanding these opportunities is essential for stakeholders aiming to capitalize on emerging trends and enhance their market position.

• Advanced imaging systems: Enhanced visualization techniques are improving surgical precision and outcomes, leading to increased adoption and demand.
• Miniaturization of devices: Smaller, more efficient tools are enabling less invasive procedures, reducing patient recovery time, and expanding treatment options.
• Integration of AI and automation: AI-driven diagnostics and automated surgical systems are increasing accuracy, efficiency, and safety in procedures.
• Telemedicine and remote surgery: Remote consultation and robotic-assisted surgeries are broadening access to specialized care, especially in remote areas.
• Customizable and patient-specific devices: Tailored solutions are improving treatment efficacy and patient satisfaction, fostering market growth.

These strategic growth opportunities are collectively transforming the vitreoretinal surgery device market in Japan. They are driving innovation, improving clinical outcomes, and expanding access to advanced treatments. As a result, market players are positioned to benefit from increased demand and technological leadership, ensuring sustained growth and competitiveness in this dynamic landscape.

Vitreoretinal Surgery Device Market in Japan Driver and Challenges

The vitreoretinal surgery device market in Japan is influenced by a complex interplay of technological advancements, economic conditions, and regulatory frameworks. Rapid innovations in surgical devices, increasing prevalence of retinal diseases, and supportive government policies are key drivers. Conversely, high costs, stringent regulations, and limited skilled professionals pose significant challenges. Understanding these factors is crucial for stakeholders aiming to capitalize on growth opportunities and address potential barriers in this specialized medical sector.

The factors responsible for driving the vitreoretinal surgery device market in Japan include:
• Technological Innovation: Rapid advancements in surgical devices, such as high-resolution imaging and minimally invasive tools, enhance surgical outcomes and attract healthcare providers to adopt new technologies.
• Rising Prevalence of Retinal Diseases: An aging population leads to increased cases of age-related macular degeneration and diabetic retinopathy, boosting demand for advanced surgical interventions.
• Healthcare Infrastructure Development: Japanese well-established healthcare system and investment in specialized ophthalmic centers facilitate the adoption of cutting-edge vitreoretinal devices.
• Government Support and Policies: Favorable regulatory environment, subsidies, and initiatives promoting medical device innovation encourage market growth.

The challenges in the vitreoretinal surgery device market in Japan are:
• High Cost of Devices: Advanced vitreoretinal surgical equipment involves significant investment, which can limit adoption among smaller clinics and hospitals.
• Stringent Regulatory Approvals: Complex approval processes and compliance requirements delay product launches and increase costs for manufacturers.
• Skilled Professional Shortage: Limited availability of trained vitreoretinal surgeons hampers the widespread adoption of new surgical devices, affecting market expansion.

In summary, technological progress and demographic trends propel the Japanese vitreoretinal surgery device market forward, while high costs, regulatory hurdles, and professional shortages present notable barriers. Addressing these challenges through innovation, policy support, and workforce development is essential for sustained growth and improved patient outcomes in this specialized field.

List of Vitreoretinal Surgery Device Market in Japan Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, vitreoretinal surgery device companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the vitreoretinal surgery device companies profiled in this report include:

• Company 1
• Company 2
• Company 3
• Company 4
• Company 5
• Company 6
• Company 7
• Company 8
• Company 9
• Company 10

Vitreoretinal Surgery Device Market in Japan by Segment

The study includes a forecast for the vitreoretinal surgery device market in Japan by product type and surgery type.

Vitreoretinal Surgery Device Market in Japan by Product Type [Analysis by Value from 2019 to 2031]:

• Perfluoro Carbon Liquids
• Endoillumination Instruments
• Vitreoretinal Prefilled Silicone Oil Syringes
• Virectomy System
• Others


Vitreoretinal Surgery Device Market in Japan by Surgery Type [Analysis by Value from 2019 to 2031]:

• Anterior Vitreoretinal Surgery
• Posterior Vitreoretinal Surgery

Features of the Vitreoretinal Surgery Device Market in Japan

Market Size Estimates: Vitreoretinal surgery device in Japan market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends and forecasts by various segments.
Segmentation Analysis: Vitreoretinal surgery device in Japan market size by product type and surgery type in terms of value ($B).
Growth Opportunities: Analysis of growth opportunities in different product types and surgery types for the vitreoretinal surgery device in Japan.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the vitreoretinal surgery device in Japan.
Analysis of competitive intensity of the industry based on Porter Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 10 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the vitreoretinal surgery device market in Japan by product type (perfluoro carbon liquids, endoillumination instruments, vitreoretinal prefilled silicone oil syringes, virectomy system, and others) and surgery type (anterior vitreoretinal surgery and posterior vitreoretinal surgery)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.4. What are the business risks and competitive threats in this market?
Q.5. What are the emerging trends in this market and the reasons behind them?
Q.6. What are some of the changing demands of customers in the market?
Q.7. What are the new developments in the market? Which companies are leading these developments?
Q.8. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.9. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.10. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?


ページTOPに戻る


Table of Contents

Table of Contents
1. Executive Summary
2. Vitreoretinal Surgery Device Market in Japan: Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2019 to 2031
3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
3.2. Vitreoretinal Surgery Device Market in Japan Trends (2019-2024) and Forecast (2025-2031)
3.3: Vitreoretinal Surgery Device Market in Japan by Product Type
3.3.1: Perfluoro Carbon Liquids
3.3.2: Endoillumination Instruments
3.3.3: Vitreoretinal Prefilled Silicone Oil Syringes
3.3.4: Virectomy System
3.3.5: Others
3.4: Vitreoretinal Surgery Device Market in Japan by Surgery Type
3.4.1: Anterior Vitreoretinal Surgery
3.4.2: Posterior Vitreoretinal Surgery
4. Competitor Analysis
4.1: Product Portfolio Analysis
4.2: Operational Integration
4.3: Porter Five Forces Analysis
5. Growth Opportunities and Strategic Analysis
5.1: Growth Opportunity Analysis
5.1.1: Growth Opportunities for the Vitreoretinal Surgery Device Market in Japan by Product Type
5.1.2: Growth Opportunities for the Vitreoretinal Surgery Device Market in Japan by Surgery Type
5.2: Emerging Trends in the Vitreoretinal Surgery Device Market in Japan
5.3: Strategic Analysis
5.3.1: New Product Development
5.3.2: Capacity Expansion of the Vitreoretinal Surgery Device Market in Japan
5.3.3: Mergers, Acquisitions, and Joint Ventures in the Vitreoretinal Surgery Device Market in Japan
5.3.4: Certification and Licensing
6. Company Profiles of Leading Players
6.1: Company 1
6.2: Company 2
6.3: Company 3
6.4: Company 4
6.5: Company 5
6.6: Company 6
6.7: Company 7
6.8: Company 8
6.9: Company 9
6.10: Company 10

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


Lucintel社はどのような調査会社ですか?


Lucintelは世界の多様な市場について調査を行っています。特に化学品、材料、自動車関連の調査レポートを数多く出版しています。  もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2025/12/10 10:27

157.88 円

183.89 円

212.70 円

ページTOPに戻る